     
|
Research Summary
Our Section investigates the
relationship between protein structure and function, mainly by the technique of
high-resolution X-ray diffraction. Some of the areas of interest are directly
involved in elucidating structural features of the molecules that could explain
their importance to understanding cancer and AIDS, but we are also active in
the development of methods for protein crystallography.
Crystallographic Studies of
Proteases
Crystallographic studies
of proteases have been an important area of research of this Section since its
establishment. We have been particularly active in the investigation of
structure-function relationship in aspartic proteases, including clinically
important retroviral enzymes. Our studies of HIV protease, although no longer a
major target of active research, are still ongoing and concentrate on the
investigation of drug-resistant variants and their complexes with inhibitors.
We have investigated structure-function relationship in retroviral proteases
from several other sources such as FIV, RSV, and HTLV-1. Cockroach allergen Bla
g 2 was shown to be an inactive aspartic protease and we solved its structure
by itself, and in a complex with several specific antibodies. We have
determined the structure of a unique histoaspartic protease, an enzyme with the
pepsin fold, but a vastly different mechanism. We found that Shigella
virulence factor VirA is a putative protease with a novel fold, and we are
examining its structural and enzymatic properties. We have established an
extensive program of investigating serine-carboxyl peptidases (sedolisins), a
family that was first characterized based on crystal structures solved in this
laboratory and that is found in many different organisms. We are also
investigating the bacterial ATP-dependent protease Lon, finding that its
proteolytic domain has a unique fold and thus establishes a new family of
proteases with a Ser-Lys catalytic dyad. We have solved the structures of the
proteolytic domain of A and B type Lon proteases, encoded by E. coli and
Archaeoglobus fulgidus, as well as the N-terminal and α domains of
E. coli Lon.
Lectins with
Antiviral Activity
We have been
involved in studies of several lectins with antiviral activities, some of them
used in pre-clinical trials as potential drugs preventing HIV infection. We
have solved the structure of griffithsin, as free protein and complexed with a
number of mono- and disaccharides, explaining the structural basis for its
tight binding to branched mannose-rich carbohydrates. We have also solved the
structure of another lectin, scytovirin, and are investigating its mode of
carbohydrate binding.
Proteins
Involved in Ribosome Biogenesis and Tumor Suppression
Two related serine protein kinases, Rio1 and
Rio2, are involved in processing 20S pre-RNA to 18S ribosomal RNA. Their
crystal structures, solved by our Section, established that they belong to a
novel family of kinases with a truncated substrate-binding region, although
they are capable of both self- and trans-phosphorylation. We have established
the sites of autophosphorylation for both of them. We are currently
investigating their catalytic properties and potential biological roles. We
have also solved the structure of the C-terminal MA3 domain of Pdcd4,
explaining how that tumor suppressor factor inhibits translation initiation.
Cytokines and Cytokine
Receptors
Our Section has been
investigating the crystal structures of several cytokines and has made progress
in preparing their receptor complexes. We have purified and crystallized
complexes of IL-10 with its specific receptor and are studying complexes of
several other cytokines related to IL-10, such as IL-19, IL-20, IL-22,
IFN-λ1 and IFN-λ2.
Our
extramural collaborators include Anna Marie Skalka, Ph.D., Fox Chase Cancer
Center; Ben Dunn, Ph.D., University of Florida; John Elder, Ph.D., The Scripps
Research Institute; Kohei Oda, Ph.D., Kyoto Institute of Technology, Kyoto,
Japan; Toru Nakayama, Ph.D., Tohoku University, Sendai, Japan; Rickey Yada,
Ph.D., University of Guelph, Guelph, Canada; Mariusz Jaskolski, D.Sc., Adam
Mickiewicz University, Poznan, Poland; and Tatyana Rotanova, D.Sc.,
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow,
Russia. |